OPKO Health Inc. [NASDAQ: OPK] plunged by -$0.19 during the normal trading session on Tuesday and reaching a high of $3.03 during the day while it closed the day at $2.79. The company report on March 16, 2022 that GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions.
New research underscores the value of sharing genomic information to advance gene matching for diagnosis and discovery.
GeneDx, Inc., a leader in genomic analysis, today announced newly published research demonstrating the value of data sharing and research participation on a platform that supports clinician connections to rapidly uncover new gene-disease relationships, an approach which has resulted in publication of more than 200 new associations.
OPKO Health Inc. stock has also loss -13.08% of its value over the past 7 days. However, OPK stock has declined by -7.31% in the 3 months of the year. Over the past six months meanwhile, it has lost -22.50% and lost -42.00% year-on date.
The market cap for OPK stock reached $2.08 billion, with 652.18 million shares outstanding and 409.90 million shares in the current float. Compared to the average trading volume of 4.28M shares, OPK reached a trading volume of 4363167 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about OPKO Health Inc. [OPK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OPK shares is $6.88 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OPK stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Barrington Research have made an estimate for OPKO Health Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on January 24, 2022. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on June 21, 2021, representing the official price target for OPKO Health Inc. stock. Previously, the target price had yet another raise to $2.50, while Piper Jaffray analysts kept a Overweight rating on OPK stock.
The Average True Range (ATR) for OPKO Health Inc. is set at 0.16, with the Price to Sales ratio for OPK stock in the period of the last 12 months amounting to 1.17. The Price to Book ratio for the last quarter was 1.08, with the Price to Cash per share for the same quarter was set at 0.18. Price to Free Cash Flow for OPK in the course of the last twelve months was 340.41 with Quick ratio for the last quarter at 2.20.
OPK stock trade performance evaluation
OPKO Health Inc. [OPK] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.08. With this latest performance, OPK shares dropped by -20.51% in over the last four-week period, additionally sinking by -22.50% over the last 6 months – not to mention a drop of -34.66% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OPK stock in for the last two-week period is set at 32.40, with the RSI for the last a single of trading hit 25.68, and the three-weeks RSI is set at 36.83 for OPKO Health Inc. [OPK]. The present Moving Average for the last 50 days of trading for this stock 3.29, while it was recorded at 2.99 for the last single week of trading, and 3.72 for the last 200 days.
OPKO Health Inc. [OPK]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and OPKO Health Inc. [OPK] shares currently have an operating margin of -0.81 and a Gross Margin at +30.30. OPKO Health Inc.’s Net Margin is presently recorded at -1.70.
Return on Equity for this stock declined to -1.80, with Return on Assets sitting at -1.24.
OPKO Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.20 and a Current Ratio set at 2.50.
Earnings per share (EPS) analysis for OPKO Health Inc. [OPK] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OPK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for OPKO Health Inc. go to 12.00%.
OPKO Health Inc. [OPK]: Insider Ownership positions
There are presently around $568 million, or 29.20% of OPK stock, in the hands of institutional investors. The top three institutional holders of OPK stocks are: VANGUARD GROUP INC with ownership of 35,725,424, which is approximately 0.732% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 34,390,912 shares of the stock with an approximate value of $102.48 million in OPK stocks shares; and STATE STREET CORP, currently with $52.67 million in OPK stock with ownership of nearly -24.385% of the company’s market capitalization.
Positions in OPKO Health Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 107 institutional holders increased their position in OPKO Health Inc. [NASDAQ:OPK] by around 23,592,464 shares. Additionally, 88 investors decreased positions by around 17,217,261 shares, while 64 investors held positions by with 149,905,850 shares. The mentioned changes placed institutional holdings at 190,715,575 shares, according to the latest SEC report filing. OPK stock had 49 new institutional investments in for a total of 12,111,763 shares, while 25 institutional investors sold positions of 1,838,724 shares during the same period.